Tilray Investors Overreacted To A Good Q1 Print, Says Cantor Fitzgerald


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Tilray Inc (NASDAQ:TLRY) reported stable first-quarter results Monday, beating expectations across key metrics.

Given this performance and upbeat management commentary around the COVID-19 impact on sales in the Canadian cannabis industry, the pressure on the company’s stock is surprising, according to Cantor Fitzgerald.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

The Tilray Analyst

Pablo Zuanic maintained a Neutral rating for Tilray and raised the price target from $7 to $8.

The Tilray Thesis

Tilray reported first-quarter sales of $52.1 million, ahead of the consensus estimate of $49.3 million and driven largely by its hemp foods business, Zuanic said in a Monday note. (See his track record here.)

COVID-induced stockpiling and new listings and promos at Costco Wholesale Corporation (NASDAQ:COST) resulted in better-than-expected growth in the cannabis business, the analyst said. 


Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


While sales of recreational cannabis grew 23% sequentially, the domestic medical cannabis business grew 21%. International cannabis sales bounced back after a decline in the previous quarter.

Tilray exited the March quarter with $174 million in cash versus $97 million at the end of fiscal 2019.

Tilray continues to expect the Canadian recreational market to double in 2020, although the coronavirus may negatively impact store openings, Zuanic said. 

The company maintained its margin and cash flow targets for the year. Given the first-quarter beat and upbeat commentary, it’s surprising that the stock ended Monday’s trading down by 6%, the analyst said. 

TLRY Price Action

Shares of Tilray were down 3.74% at $ 7.78 at the time of publication Tuesday.

Related Links:

Tilray Shares Fall On Q1 Results

Cannabis Stock Gainers And Losers From May 4, 2020


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Analyst ColorCannabisEarningsNewsGuidancePrice TargetReiterationMarketsAnalyst RatingsCantor FitzgeraldPablo Zuanic